Q4 2022 13F Holders as of 12/31/2022
-
Type / Class
-
Equity / Common Stock
-
Shares outstanding
-
106M
-
Number of holders
-
239
-
Total 13F shares, excl. options
-
83.4M
-
Shares change
-
-2.31M
-
Total reported value, excl. options
-
$1.69B
-
Value change
-
-$55.2M
-
Put/Call ratio
-
4.4
-
Number of buys
-
132
-
Number of sells
-
-87
-
Price
-
$20.31
Significant Holders of CORCEPT THERAPEUTICS INC - Common Stock (CORT) as of Q4 2022
276 filings reported holding CORT - CORCEPT THERAPEUTICS INC - Common Stock as of Q4 2022.
CORCEPT THERAPEUTICS INC - Common Stock (CORT) has 239 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 83.4M shares
of 106M outstanding shares and own 78.75% of the company stock.
Largest 10 shareholders include BlackRock Inc. (16.3M shares), VANGUARD GROUP INC (10.3M shares), RENAISSANCE TECHNOLOGIES LLC (7.29M shares), INGALLS & SNYDER LLC (6.83M shares), Parallel Advisors, LLC (3.72M shares), Novo Holdings A/S (3.38M shares), FEDERATED HERMES, INC. (3.27M shares), STATE STREET CORP (3.2M shares), DIMENSIONAL FUND ADVISORS LP (2.09M shares), and Boston Trust Walden Corp (1.85M shares).
This table shows the top 239 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.